{
  "trial_id": "NCT01732107",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed early stage urothelial carcinoma of the bladder defined as Ta, T1, or Tis stage.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Presence of either an FGFR3 mutation or FGFR3 over-expression within bladder tumor tissue.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Documented BCG-refractory disease defined as failure to achieve a tumor free state after at least 2 prior induction courses of intravesical BCG therapy.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Medically unfit to undergo cystectomy or electively choosing to forego cystectomy.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients who give a written informed consent obtained according to local guidelines.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with muscle-invasive (i.e. T2, T3, T4), locally advanced non-resectable, or metastatic urothelial carcinoma as assessed on baseline radiographic imaging obtained within 28 days prior to study registration.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with concurrent upper urinary tract (i.e. ureter, renal pelvis) non-invasive urothelial carcinoma.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 63-year-old man presenting to the Emergency Department with a history of acute urinary retention in the past 2 days.",
  "_meta": {
    "topic_id": "60",
    "trial_id": "NCT01732107",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}